ASX - By Stock
|
VMM |
Re:
Ann: Trading Halt
|
|
Specwarop
|
147 |
27K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
147
|
27K
|
1
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Trading Halt
|
|
Specwarop
|
147 |
27K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
147
|
27K
|
3
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Trading Halt
|
|
Specwarop
|
147 |
27K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
147
|
27K
|
1
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Trading Halt
|
|
Specwarop
|
147 |
27K |
13 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
147
|
27K
|
13
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Colossus Achieves Highest Overall Bulk Ionic Recoveries
|
|
Specwarop
|
42 |
11K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
42
|
11K
|
2
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Step-Out Drilling Intercepts up to 24,894ppm TREO
|
|
Specwarop
|
139 |
23K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
139
|
23K
|
1
|
|
ASX - By Stock
|
BFL |
Re:
Ann: 2023 Full Year Results Investor Presentation
|
|
Specwarop
|
6 |
1.6K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
6
|
1.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
Specwarop
|
65 |
23K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
65
|
23K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Preliminary Final Report
|
|
Specwarop
|
10 |
5.2K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
10
|
5.2K
|
2
|
|
ASX - By Stock
|
BFL |
Re:
Ann: Dividend/Distribution - BFL
|
|
Specwarop
|
8 |
2.0K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
8
|
2.0K
|
0
|
|
ASX - By Stock
|
BFL |
Re:
Ann: Dividend/Distribution - BFL
|
|
Specwarop
|
8 |
2.0K |
0 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
8
|
2.0K
|
0
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Application for quotation of securities - VMM
|
|
Specwarop
|
51 |
8.3K |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
51
|
8.3K
|
0
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Viridis Completes A$4.5 Million Placement
|
|
Specwarop
|
239 |
51K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
239
|
51K
|
0
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Viridis Completes A$4.5 Million Placement
|
|
Specwarop
|
239 |
51K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
239
|
51K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Specwarop
|
32 |
11K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
32
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
Specwarop
|
28 |
7.8K |
2 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.8K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
Specwarop
|
28 |
7.8K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.8K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
all will be revealed.
|
|
Specwarop
|
5 |
3.6K |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
5
|
3.6K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Specwarop
|
200 |
55K |
0 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
200
|
55K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Specwarop
|
200 |
55K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
200
|
55K
|
1
|
|
ASX - By Stock
|
BMM |
Re:
Ann: Visual Spodumene From Koshman Prospect at Gorge
|
|
Specwarop
|
22 |
8.2K |
0 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
22
|
8.2K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Cleansing Notice
|
|
Specwarop
|
34 |
11K |
0 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Cleansing Notice
|
|
Specwarop
|
34 |
11K |
0 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Cleansing Notice
|
|
Specwarop
|
34 |
11K |
1 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Specwarop
|
200 |
55K |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
200
|
55K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on Equity Raising
|
|
Specwarop
|
28 |
9.9K |
4 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
28
|
9.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on Equity Raising
|
|
Specwarop
|
28 |
9.9K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
28
|
9.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
Specwarop
|
87 |
29K |
0 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
87
|
29K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
Specwarop
|
87 |
29K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
87
|
29K
|
4
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Further Exceptional Discoveries Continue at Colossus
|
|
Specwarop
|
70 |
18K |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
70
|
18K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
Specwarop
|
74 |
23K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
74
|
23K
|
1
|
|
ASX - By Stock
|
VMM |
Re:
Ann: Viridis Appoints Chief Executive Officer
|
|
Specwarop
|
53 |
10K |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
53
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
Specwarop
|
74 |
23K |
4 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
74
|
23K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
Specwarop
|
40 |
13K |
10 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
40
|
13K
|
10
|
|
ASX - By Stock
|
BMM |
Re:
Ann: Drilling Commences at the Gorge Lithium Project
|
|
Specwarop
|
19 |
4.7K |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
19
|
4.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris to Present at Cantor Healthcare Conference
|
|
Specwarop
|
73 |
26K |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
73
|
26K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort
|
|
Specwarop
|
35 |
13K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
35
|
13K
|
0
|
|
ASX - By Stock
|
WDS |
Re:
Sentiment Shift on WDS
|
|
Specwarop
|
26 |
10K |
1 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
26
|
10K
|
1
|
|
ASX - By Stock
|
VAR |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Specwarop
|
3 |
1.3K |
1 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
VAS |
Re:
Ann: Estimated Distribution Announcement
|
|
Specwarop
|
6 |
6.1K |
3 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
6
|
6.1K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
|
|
Specwarop
|
47 |
18K |
3 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
47
|
18K
|
3
|
|
ASX - By Stock
|
PRL |
Re:
Ann: Voluntary Suspension Extension
|
|
Specwarop
|
40 |
28K |
2 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
40
|
28K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change in substantial holding
|
|
Specwarop
|
16 |
6.7K |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
16
|
6.7K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on First In Human DurAVR THV Study
|
|
Specwarop
|
41 |
14K |
1 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
41
|
14K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice x4
|
|
Specwarop
|
5 |
3.2K |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
5
|
3.2K
|
1
|
|
ASX - By Stock
|
TUL |
Re:
Ann: Tulla Resources Completes Funding
|
|
Specwarop
|
4 |
1.4K |
4 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
4
|
1.4K
|
4
|
|
ASX - By Stock
|
MNB |
Re:
Ann: RNT-EP affirms support for Green Hydrogen & Ammonia Project
|
|
Specwarop
|
187 |
55K |
0 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
187
|
55K
|
0
|
|
ASX - By Stock
|
BMM |
Re:
Ann: Half Yearly Report and Accounts
|
|
Specwarop
|
1 |
1.0K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
1
|
1.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
Specwarop
|
138 |
52K |
0 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
138
|
52K
|
0
|
|
ASX - By Stock
|
NTM |
Re:
Ann: Trading Halt
|
|
Specwarop
|
24 |
6.9K |
1 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
24
|
6.9K
|
1
|
|